UK Mirror, March 2016: “Woman Died After NHS Electric Shock Therapy Was Given Without Consent or Second Opinion” Senior Coroner Derek Winter, expressed concern to the UK Health Secretary about the circumstances that resulted in the death of a mentally ill woman . . . Continue reading →
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →
FDA’s lax approval process for medical devices has shielded surgeons and manufacturers who have made a killing from a lucrative business venture. FDA has even awarded the seal of approval years after the rings were implanted in patients while still in the experimental stage–without their knowledge or informed consent. Continue reading →
Panel Chairman Thomas G. Brott, a neurologist at the Mayo Clinic, said he was amazed that essentially no research had been done on ECT’s effects using functional MRI imaging, repeated brain wave (EEG) studies, or autopsy examinations of patients. Continue reading →
At the end of today’s hearings, an FDA advisory panel will issue recommendations about whether manufacturers of electroconvulsive devices must put their devices to rigorous safety tests or whether they should be reclassified from Class III (high risk) to Class II (moderate . . . Continue reading →
"Despite ongoing controversy, there has never been a large-scale, prospective study of the cognitive effects of electroconvulsive therapy (ECT)." Dr. Harold Sackeim, et al, 2007.
It may come as a shock to some of you; but, Electroshock machines have never been tested for safety or efficacy. Continue reading →
Landmark Decision: Jury awards $635,177 Damages for Memory Loss from Electroshock Fri, 8 Jul 2005 Below is a press release by Linda Andre, president of Committee for Truth in Psychiatry (CTIP) about the first ever lawsuit in which a jury found a . . . Continue reading →
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000. Continue reading →
On Wednesday, the FDA Pediatric Advisory Committee handed the agency a mixed message regarding warnings about selective list of
psychotropic drugs prescribed for treating ADHD symptoms. Continue reading →